Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
To compare the overall survival of thalidomide- and placebo-treated advanced HCC patients.
Carcinoma, Hepatocellular
DRUG: Thalidomide(Thado)
overall survival
To compare the overall survival of thalidomide- and placebo-treated advanced HCC patients.